SP1 and glioblastoma: In addition, both Sp1 and CYP17A1 positivity significantly correlated with the prognosis of GBM patients in the TCGA database, thus further supporting the oncogenic role of the Sp1–CYP17A1 axis in GBM (Figure 5b).